WCM Investment Management
CLB icon

WCM Investment Management’s Core Laboratories CLB Stock Holding History

WCM Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,113,493
Closed -$215M – 153
2019
Q1 		$215M Sell
3,113,493
-1,798,736
-37% -$121M 1.49% 13
2018
Q4 		$293M Buy
4,912,229
+42,169
+0.9% +$3.64M 2.62% 12
2018
Q3 		$564M Sell
4,870,060
-415,096
-8% -$46.8M 5.05% 9
2018
Q2 		$667M Buy
5,285,156
+249,329
+5% +$30.3M 6.9% 7
2018
Q1 		$545M Buy
5,035,827
+242,096
+5% +$26.8M 5.1% 7
2017
Q4 		$525M Buy
4,793,731
+250,830
+6% +$25M 5.94% 7
2017
Q3 		$448M Buy
4,542,901
+109,726
+2% +$10.6M 5.66% 9
2017
Q2 		$449M Buy
4,433,175
+303,073
+7% +$32.7M 6.93% 7
2017
Q1 		$477M Buy
4,130,102
+181,025
+5% +$21M 5.16% 7
2016
Q4 		$474M Buy
3,949,077
+145,705
+4% +$16.1M 5.72% 5
2016
Q3 		$427M Buy
3,803,372
+215,206
+6% +$24.8M 4.87% 6
2016
Q2 		$445M Buy
3,588,166
+181,958
+5% +$22M 7.09% 4
2016
Q1 		$383M Buy
3,406,208
+217,755
+7% +$22.6M 5.95% 5
2015
Q4 		$347M Buy
3,188,453
+981,243
+44% +$112M 7.11% 5
2015
Q3 		$220M Buy
2,207,210
+172,255
+8% +$18.7M 5.49% 9
2015
Q2 		$232M Buy
2,034,955
+571,888
+39% +$69.3M 5.22% 10
2015
Q1 		$153M Buy
1,463,067
+238,881
+20% +$25.4M 3.09% 11
2014
Q4 		$147M Buy
1,224,186
+195,580
+19% +$25.7M 4.26% 12
2014
Q3 		$151M Buy
1,028,606
+289,556
+39% +$44.7M 4.64% 10
2014
Q2 		$123M Buy
739,050
+202,889
+38% +$36.1M 3.08% 12
2014
Q1 		$106M Buy
536,161
+16,344
+3% +$3.08M 3.81% 9
2013
Q4 		$99.3M Buy
519,817
+74,770
+17% +$13.9M 3.58% 8
2013
Q3 		$75.8M Buy
445,047
+6,522
+1% +$1.01M 3.96% 4
2013
Q2 		$66.8M Buy
+438,525
New +$62.1M 3.6% 3

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

WCM Investment Management's CLB Position: Q2 2019 in Review

WCM Investment Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 3,113,493 shares — an estimated $215M sold.

WCM Investment Management first reported a position in CLB in Q2 2013 and held it in 24 quarters. The position peaked at $667M in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • WCM Investment Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
  • WCM Investment Management sold 3,113,493 Core Laboratories shares in Q2 2019, an estimated $215M.
  • WCM Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 24 quarters.
  • WCM Investment Management's Core Laboratories position peaked at $667M in Q2 2018.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on WCM Investment Management's 13F filing for Q2 2019, filed 6 Aug 2019.